<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.1//EN" "ep-patent-document-v1-1.dtd">
<ep-patent-document id="EP00912310B8W1" file="EP00912310W1B8.xml" lang="en" country="EP" doc-number="1165106" kind="B8" correction-code="W1" date-publ="20050727" status="c" dtd-version="ep-patent-document-v1-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYAL..............................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001)
 2999001/0</B007EP></eptags></B000><B100><B110>1165106</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20050727</date></B140><B150><B151>W1</B151><B153>72</B153><B155><B1551>DE</B1551><B1552>Bibliographie</B1552><B1551>EN</B1551><B1552>Bibliography</B1552><B1551>FR</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>00912310.0</B210><B220><date>20000330</date></B220><B240><B241><date>20010921</date></B241><B242><date>20020926</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>127451 P</B310><B320><date>19990401</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20050727</date><bnum>200530</bnum></B405><B430><date>20020102</date><bnum>200201</bnum></B430><B450><date>20050525</date><bnum>200521</bnum></B450><B452EP><date>20041021</date></B452EP><B480><date>20050727</date><bnum>200530</bnum></B480></B400><B500><B510><B516>7</B516><B511> 7A 61K  35/74   A</B511><B512> 7A 61K  31/7088 B</B512><B512> 7A 61P  35/00   B</B512></B510><B540><B541>de</B541><B542>ZUSAMMENSETZUNG UND METHODE ZUR INDUZIERUNG VON APOPTOSIS IN PROSTATAKREBSZELLEN MITTELS M-DNA UND MCC</B542><B541>en</B541><B542>COMPOSITION AND METHOD FOR INDUCING APOPTOSIS IN PROSTATE CANCER CELLS BY M-DNA AND MCC</B542><B541>fr</B541><B542>COMPOSITION ET PROCEDE PERMETTANT D'INDUIRE UNE APOPTOSE DANS DES CELLULES CANCEREUSES DE LA  PROSTATE Ä L'AIDE DE M-DNA ET MCC</B542></B540><B560><B561><text>WO-A-99/07383</text></B561><B562><text>MORALES A ET AL: "Immunotherapy of an experimental adenocarcinoma of the prostate" JOURNAL OF UROLOGY,US,BALTIMORE, MD, vol. 153, May 1995 (1995-05), pages 1706-1710, XP002100764 ISSN: 0022-5347</text></B562><B562><text>FILION M C ET AL: "Mycobacterium phlei cell wall complex, a new anti-tumoral agent, induces IL-12 synthesis by monocyte-macrophages via associated DNA" BLOOD,US,W.B. SAUNDERS, PHILADELPHIA, VA, vol. 90, no. 10, SUPPL. 01, 5 December 1997 (1997-12-05), page 58B XP002085542 ISSN: 0006-4971</text></B562><B562><text>FILION M C ET AL: "MYCOBACTERIAL CELL WALL - DNA COMPLEX INDUCES APOPTOSIS IN CANCER CELLS" JOURNAL OF PHARMACY AND PHARMACOLOGY,LONDON,GB, vol. 50, no. SUPPL, September 1998 (1998-09), page 39 XP000892394 ISSN: 0022-3573</text></B562><B562><text>FILION M C ET AL: "Mycobacterium phlei cell wall complex directly induces apoptosi in human bladder cancer cells" BRITISH JOURNAL OF CANCER,GB,LONDON, vol. 79, no. 2, January 1999 (1999-01), pages 229-235, XP002100762 ISSN: 0007-0920</text></B562><B562><text>READER S ET AL: "Mycobacterial cell wall-DNA complex (MCC) inhibits proliferation and induces apoptosis in androgen-dependent and independent human prostate cancer cells." BRITISH JOURNAL OF CANCER, vol. 80, no. SUPPL. 2, July 1999 (1999-07), page 76 XP000946798 Joint Meeting of the British Association for Cancer Research, the British Oncological Association, the Association of Cancer Physicians and the Royal College of Radiologists;Edinburgh, Scotland, UK; July 11-14, 1999 ISSN: 0007-0920</text></B562></B560></B500><B700><B720><B721><snm>PHILLIPS, Nigel, C.</snm><adr><str>101 Seigniory Avenue</str><city>Point-Claire, Quebec H9R 1J6</city><ctry>CA</ctry></adr></B721><B721><snm>FILION, Mario, C.</snm><adr><str>2377 St. Zotique</str><city>Montreal, Quebec H2G 1K3</city><ctry>CA</ctry></adr></B721><B721><snm>READER, Stéphanie</snm><adr><str>1791 D'argenson</str><city>Ste-Julie, Quebec, J3E 1E3</city><ctry>CA</ctry></adr></B721></B720><B730><B731><snm>Bioniche Life Sciences Inc.</snm><iid>03093052</iid><irf>26362P EP-WO MD</irf><adr><str>231 Dundas Street E.</str><city>Belleville,
Ontario K8N 5J2</city><ctry>CA</ctry></adr></B731></B730><B740><B741><snm>Dey, Michael, Dr.</snm><sfx>et al</sfx><iid>00094541</iid><adr><str>Weickmann &amp; Weickmann,
Patentanwälte,
Postfach 86 08 20</str><city>81635 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20010921</date></B845EP><B845EP><ctry>LT</ctry><date>20010921</date></B845EP><B845EP><ctry>LV</ctry><date>20010921</date></B845EP><B845EP><ctry>MK</ctry><date>20010921</date></B845EP><B845EP><ctry>RO</ctry><date>20010921</date></B845EP><B845EP><ctry>SI</ctry><date>20010921</date></B845EP></B844EP><B860><B861><dnum><anum>CA2000000342</anum></dnum><date>20000330</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2000059518</pnum></dnum><date>20001012</date><bnum>200041</bnum></B871></B870><B880><date>20010201</date><bnum>000000</bnum></B880></B800></SDOBI>
</ep-patent-document>
